Submacular hemorrhage is a rare but devastating sequel of choroidal neovascularization, which is a frequent complication of age-related macular degeneration (AMD). It is serious because it interferes ...

Please provide your email address to receive an email when new articles are posted on . At the American Academy of Ophthalmology meeting, Catherine Creuzot-Garcher, MD, PhD, said there is currently no ...

Please provide your email address to receive an email when new articles are posted on . NEW YORK — Vitrectomy using balanced saline solution without tissue plasminogen activator is effective for ...

To evaluate the efficacy of anti-vascular endothelial growth factor (VEGF) monotherapy for large submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD). A total ...

The purpose of this study is to investigate the factors associated with reactivation of the lesion during the first year in patients with polypoidal choroidal vasculopathy (PCV) treated with ...

Both anti-VEGF and surgical treatments improve VA in AMD-related submacular hemorrhage, with no statistically significant difference between the two treatments. Anti-VEGF injections may be associated ...

“Currently, there is a lack of evidence-based research and rigorous guidelines for the management of patients with SMH secondary to nAMD [neovascular AMD],” said Dr. Gabrielle, who is based at the ...

A recent study found that men and patients with disciform scars on their eyes have a greater risk of developing submacular hemorrhage (SMH), a rare complication in the eyes. For patients treated with ...